tropomyosin-receptor kinase-B/C co-stimulator (PharmatrophiX/University of California San Francisco/Standford University)

N/A

Report date: 2025/06/11 10:30:08
NME

Base Information

Drug Nametropomyosin-receptor kinase-B/C co-stimulator (PharmatrophiX/University of California San Francisco/Standford University)
Drug Alias NamePTX-BD10-2BC-2 (PharmatrophiX)
ClassificationSmall molecules
Mechanisms of ActionNeuroprotectantsNeurotrophic tyrosine kinase receptor type 2 stimulantsBeta amyloid A4 protein inhibitors +[4] 
TargetsNeurotrophic tyrosine kinase receptor type 2Beta amyloid A4 proteinNeurotrophic tyrosine kinase receptor type 3
Therapy Area/IndicationsAlzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPharmatrophix Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California San FranciscoStanford UniversityPharmatrophix Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A